DoreenZhu University of OxfordUnited Kingdom

DoreenZhu
Dr Doreen Zhu is an Academic Clinical Lecturer based in the Renal Studies Group at the Clinical Trial Service Unit (CTSU) and Oxford Population Health (OxPop) in the University of Oxford, United Kingdom. She started nephrology and general medicine clinical training in 2016 and was appointed as a Clinical Research Fellow in 2018 for three years. During this time, she completed a MD exploring the associations of blood pressure with kidney outcomes in the Mexico City Prospective Study and worked on the EMPA-KIDNEY trial, which tested whether empagliflozin prevents worsening of kidney disease or deaths from heart disease in people with chronic kidney disease. For her postdoctoral research, she hopes to study the associations of genetically-predicted risk factors with kidney outcomes and to develop her knowledge and experience of clinical trials, testing new treatments aimed at managing and reducing the progression of chronic kidney disease.
Institution

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
Insights From Understanding Heterogeneous Trajectories to Kidney Failure
FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina
Magdalena Madero Chairperson Chief of Nephrology, Instituto Nacional de CardiolMexico
PietroRavani Chairperson pravani@ucalgary.caUniversity of CalgaryCanada
  • Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function
    JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States
  • Understanding the Heterogeneous Trajectory of CKD
    MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States
  • Review of Medical Therapies Proven to Delay CKD Progression
    DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom
  • Impact of Obesity and Novel Treatment Strategies on CKD Progression
    PeterRossing Speaker Steno Diabetes Center Copenhagen Denmark
  • Q and A
Hall C4